COVID-19 Vaccine Equity: A Health Systems and Policy Perspective
34 Pages Posted: 30 Jun 2021
Date Written: May 31, 2021
The global COVID-19 vaccine rollout has highlighted inequities in the accessibility of countries to COVID -19 vaccines. Populations in low- and middle-income countries have found it difficult to have access to COVID-19 vaccines. This perspective provides analyses on historical and contemporary policy trends of vaccine development and immunization programs, including the current COVID-19 vaccination drive, and governance challenges. Moreover, we also provide a comparative health system analysis of the COVID-19 vaccine deployment in some countries from different continents. It recommends that the international Access to COVID-19 Tools Accelerator (ACT-A) partnership requires a strong governance mechanism and urgent financial investment. All WHO member states should agree on technology transfer and voluntary license-sharing via a commonly governed technology access pool. Contextualized, dynamic understandings and country-specific versions of health systems strengthening are needed to improve vaccine equity in a sustainable matter.
Note: Funding Statement: None.
Declaration of Interests: None.
Keywords: ACT-A, capacity development, COVID-19 pandemic, vaccine equity, low-income countries, Research & Development ecosystem, Tanahashi health systems framework, technology transfer, TRIPS
Suggested Citation: Suggested Citation